Results for tag: "Vedaprofen"

Vedaprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat musculoskeletal disorders. It is used to reduce inflammation and pain associated with conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Vedaprofen is available in both oral and injectable forms. It is also used to treat acute pain and postoperative pain. Vedaprofen is a relatively new drug and is not yet widely available in the market. The Vedaprofen market is expected to grow in the coming years due to the increasing prevalence of musculoskeletal disorders. The growing demand for effective treatments for these conditions is expected to drive the growth of the Vedaprofen market. Additionally, the increasing awareness about the benefits of Vedaprofen is expected to further fuel the growth of the market. Some of the key players in the Vedaprofen market include Pfizer, Merck & Co., Inc., Novartis AG, Sanofi, and GlaxoSmithKline plc. Show Less Read more